Epitope mapping studies with human anti-cytochrome P450 3A antibodies

Molecular Pharmacology

Volumn 49, Issue 2, 1996, Pages 234-243

  Leeder, J Steven ^a,b   Gaedigk, Andrea ^a   Lu, Xiaoli ^a   Cook, Vicki A ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CYTOCHROME P450; ENZYME ANTIBODY; EPITOPE; PHENOBARBITAL; PHENYTOIN;

ANTIBODY PRODUCTION; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; GENE MAPPING; HUMAN; HYPERSENSITIVITY REACTION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTICONVULSANTS; BASE SEQUENCE; BINDING SITES, ANTIBODY; BLOTTING, WESTERN; CONSENSUS SEQUENCE; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; DRUG HYPERSENSITIVITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES; GENE LIBRARY; HAPTENS; HUMANS; IMMUNOHISTOCHEMISTRY; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; RATS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0030063547     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Nelson, D. R., T. Kamataki, D. J. Waxman, F. P. Guengerich, R. W. Estabrook, R. Feyereisen, F. J. Gonzalez, M. J. Coon, I. C. Gunsalus, O. Gotoh, K. Okuda, and D. W. Nebert. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 12:1-51 (1993).
2. Gueguen, M., M. Meunier-Rotival, O. Bernard, and F. Alvarez. Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID family J. Exp. Med. 168:801-806 (1988).
3. Manns, M. P., E. F Johnson, K. J. Griffin, E. M. Tan, and K. F. Sullivan. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J. Clin. Invest. 83:1066-1072 (1989).
4. Manns, M. P , K. J. Griffin, L. C. Quattrochi, M. Sacher, H. Thaler, R. H. Tukey, and E. F. Johnson. Identification of cytochrome P450IA2 as a human autoantigen. Arch. Biochem. Biophys. 280:229-232 (1990).
5. Winqvist, O., J. Gustafsson, F. Rorsman, F. A. Karlsson, and O. Kampe. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J. Clin. Invest. 92:2377-2385 (1993).
6. Winqvist, O., F. A. Karlsson, and O. Kämpe. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 339:1559-1562 (1992).
7. Krohn, K., R Uibo, E. Aavik, P. Peterson, and K. Savilahti. Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17α-hydroxylase. Lancet 339:770-773 (1992).
8. Beaune, P., P. M. Dansette, D. Mansuy, L Kiffel, M. Finck, C. Amar, J. P. Leroux, and J. C. Homberg. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc. Natl. Acad. Sci. USA 84:551-555 (1987).
9. Bourdi, M., D. Larrey, J. Nataf, J. Bernuau, D. Pessayre, M. Iwasaki, F P. Guengerich, and P. H Beaune. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. J. Clin. Invest. 85:1967-1973 (1990).
10. Leeder, J. S., R. J. Riley, V. A. Cook, and S. P. Spielberg. Human anticytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions. J. Pharmacol. Exp Ther. 263:360-367 (1992).
11. Riley, R. J., G. Smith, C. R. Wolf, V. A. Cook, and J S. Leeder. Human anti-endoplasmic reticulum antibodies produced in aromatic anticonvulsant hypersensitivity reactions recognise rodent CYP3A proteins and a similarly regulated human P450 enzyme(s). Biochem. Biophys. Res. Commun. 191:32-40 (1993).
12. Manns, M. P., K. J. Griffen, K. F. Sullivan, and E. F. Johnson. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P450 monooxygenase. J. Clin. Invest. 88:1370-1378 (1991).
13. Gueguen, M., O. Boniface, O. Bernard, F. Clerc, T. Cartwright, and F. Alvarez. Identification of the main epitope on human cytochrome P450 IID6 recognized by anti-liver kidney microsome antibody. J. Autoimmun. 4:607-615 (1991)
14. Yamamoto, A. M., D Cresteil, O. Boniface, F. F. Clerc, and F. Alvarez. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1). Eur. J. Immunol. 23:1105-1111 (1993).
15. Park, B. K., J. W. Coleman, and N. R. Kitteringham. Drug disposition and drug hypersensitivity. Biochem. Pharmacol. 36:581-590 (1987).
16. López-Garcia, M. P., P. M. Dansette, P. Valadon, C. Amar, P. H. Beaune, F. P. Guengerich, and D. Mansuy. Human liver cytochromes P-450 expressed in yeast as tools for reactive-metabolite formation studies: oxidative activation of tienilic acid by cytochromes P-450 2C9 and 2C10. Eur. J. Biochem. 213:223-232 (1993).
17. López-Garcia, M. P., P. M. Dansette, and D. Mansuy. Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid. Biochemistry 33:166-175 (1994).
18. Lecoeur, S., E. Bomerbale, D. Challine, J C. Gautier, P. Valadon, P. M. Dansette, R. Catinot, F. Ballet, D. Mansuy, and P. Beaune. Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs. Chem. Res Toxicol. 7:434-442 (1994).
19. Leeder, J. S., V. A. Cook, and E. J. Riley. Anti-cytochrome P450 antibodies in patients with aromatic anticonvulsant-induced hypersensitivity reactions, in Cytochrome P450 Biochemistry, Biophysics and Molecular Biology (M. C. Lechner, ed.). John Libbey Eurotext, Paris, 197-200 (1994).
20. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 227:680-685 (1970).
21. Shear, N. H., and S. P. Spielberg. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. J. Clin. Invest. 82:1826-1832 (1988)
22. Yamamoto, A. M., D. Cresteil, J. C. Homberg, and F. Alvarez. Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera. Gastroenterology 104:1762-1767 (1993)
23. Bednarek, J., J. Furmaniak, N. Wedlock, Y. Kiso, A. Baumann-Antczak, S. Fowler, H. Krishnan, J. A. Craft, and B. Rees Smith. Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease. FEBS Lett. 309:51-55 (1992)
24. Song, Y. H., E. L. Connor, A. Muir, J. X. She, B. Zorovich, D. Derovanesian, and N. Maclaren. Autoantibody epitope mapping of the 21-hydroxylase antigen in autoimmune Addison's disease. J. Clin. Endocrinol. Metab. 78:1108-1112 (1994).
25. Peterson, P., and K. J. E. Krohn. Mapping of B cell epitopes on steroid 17α-hydroxylase, an autoantigen in autoimmune polyglandular syndrome type I. Clin. Exp. Immunol. 98:104-109 (1994).
26. Kennelly, P. J., and E. G. Krebs. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J. Biol. Chem. 266:15555-15558 (1991).
27. Ravichandran, K. G., S. S. Boddupalli, C. A. Hasemann, J. A. Peterson, and J. Deisenhofer. Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. Science (Washington D. C.) 261:731-736 (1993).
28. Loeper, J., V. Descatoire, M. Maurice, P. Beaune, J. Belghiti, D. Houssin, F. Ballet, G. Feldman, F. P. Guengerich, and D. Pessayre. Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology 104:203-216 (1993).
29. Yamamoto, A M., C. Mura, C. de Lemos-Chiarnadini, and R. Krishnamoorthy. Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes. Clin. Exp. Immunol. 92:381-390 (1993).
30. Correia, M. A., C. Decker, K. Sugiyama, P. Caldera, L. Bornheim, S. A. Wrighton, A. E. Rettie, and W F. Trager. Degradation of rat hepatic cytochrome P-450 heme by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine to irreversibly bound protein adducts. Arch. Biochem. Biophys. 258:436-151 (1987).
31. Correia, M. A., K. Yao, S. A. Wrighton, D. J. Waxman, and A. E. Rettie Differential apoprotein loss of rat liver cytochromes P450 after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: a case for distinct proteolytic mechanisms? Arch. Biochem. Biophys. 294: 493-503 (1992).
32. Correia, M. A., S. H. Davoll, S A. Wrighton, and P. E. Thomas. Degradation of rat liver cytochromes P450 3A after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: characterization of the proteolytic system. Arch. Biochem. Biophys. 297:228-238 (1992).
33. Michaelek, M. T., E. P. Grant, C. Gramm, A. L Goldberg, and K. L. Rock A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature (Lond.) 363:552-554 (1993).
34. Gotoh, O. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J. Biol. Chem. 267:83-90 (1992).
35. Picado-Leonard, J., and W. L. Miller. Homologous sequences in steroidogenic enzymes, steroid receptors and a steroid binding protein suggest a consensus steroid-binding sequence. Mol. Endocrinol. 2:1145-1150 (1988).
36. Aoyama, T., K. Korzekwa, K. Nagata, J. Gillette, H. V. Gelboin, and F. J Gonzalez. Estradiol metabolism by complementary deoxyribonucleic acid-expressed human cytochrome P450s. Endocrinology 126:3101-3106 (1990).
37. Waxman, D. J , D. P. Lapenson, T. Aoyama, H. V. Gelboin, P. J. Gonzalez, and K. Korzekwa. Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch. Biochem. Biophys. 290: 160-166 (1991).
38. Hall, S. D., M. A. Hamman, A. E. Rettie, L. C. Wienkers, W. F. Trager, M. Vandenbranden, and S. A. Wrighton. Relationships between the levels of eytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes. Drug Metab Dispos. 22:975-978 (1994).
39. Pirmohamed, M., N. R. Kitteringham, A. M. Breckenridge, and E. K. Park. The effect of enzyme induction on the cytochrome P450-mediated bioactivation of carbamazepine by mouse liver microsomes. Biochem. Pharmacol. 44:2307-2314 (1992).
40. Kerr, B. M., K. E. Thummel, C. J. Wurden, S. M. Klein, D. L. Kroetz, F. J. Gonzalez, and R. H. Levy. Human liver carbamazepine metabolism: role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem. Pharmacol. 47:1969-1979 (1994).